ORYZON collaborates with the CMT Research Foundation in the US 26/07/2022 Healthcare To explore Oryzon’s HDAC6 inhibitors on Charcot-Marie-Tooth disease CMTRF to provide funding for in vivo efficacy tests... Partners - Oryzon Genomics
ZYMVOL lands in Boston, expands towards health-related enzyme projects 20/07/2022 Healthcare The company plans to continue pushing forward the development of in silico enzyme discovery and design projects in the... Partners - Zymvol Biomodeling
ORYZON enters cooperative research and development agreement (CRADA) with U.S. National Ca... 19/07/2022 Healthcare Oryzon and NCI will collaborate to assess the safety and efficacy of iadademstat in oncology patients with different... Partners - Oryzon Genomics
Lebrikizumab maintains skin clearance over one year in atopic dermatitis monotherapy trial... 18/07/2022 Healthcare Almirall recently announced topline results from one-year analyses of the efficacy and safety of lebrikizumab, an... Partners - Almirall
ADNTRO Genetics, a Spanish start-up with a multidisciplinary team involved in the bioinfor... 18/07/2022 Healthcare The analysis focuses on genomic data provided by various genomic technologies Partners - ADNTRO GENETICS SL
BCN HEALTH presents three communications in the congress ILC assessing clinical and econom... 14/07/2022 Healthcare Corporate BCN HEALTH presents the poster "Increased baseline comorbidity burden including liver severity among HDV/HBV coinfection... Partners - BCN Health
The occasion of the VCoE Members' Meeting 13/07/2022 Healthcare Corporate The Venture Centre of Excellence, a public-private co-investment programme of EIT Health and the European investment... Partners
3P Biopharmaceuticals and Biosergen complete together the manufacture of biomass for the M... 11/07/2022 Healthcare Biosimilars Industrial biotechnology Mucormycosis is a difficult to treat invasive fungal infection with high mortality Partners - 3PBIOVIAN
BCN HEALTH publica un estudio evaluando la incidencia hospitalaria y los costes médicos as... 04/07/2022 Healthcare Corporate BCN HEALTH has published the study ‘Hospital incidence and costs of congenital hydrocephalus in Spain: a multicenter... Partners - BCN Health
Zendal group increases its support for new research projects and doubles the amount of it... 29/06/2022 Healthcare Corporate The biotechnological group celebrates this year the 3rd edition of the International Zendal Awards, endowed in this call... Partners - Zendal
